Physician profile
George D Silver
NPI 1366405581
$8,811.07
in general payments reported to CMS, 2019-2025
18 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,471 · 2020: $999 · 2021: $1,758 · 2022: $712 · 2023: $513 · 2024: $1,976 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,665 · Travel and Lodging: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,664.63 |
| Travel and Lodging | $1,206.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,598.57 | 2019-2024 | Grafix Pl, Stravix, Grafix |
| Medical Device Business Services, INC. | $1,325.99 | 2024 | |
| Arthrosurface Incorporated | $1,154.88 | 2019-2020 | |
| Paragon 28, INC. | $1,004.31 | 2019 | |
| Kerecis Limited | $340.41 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $335.69 | 2024-2025 | Motoband, Na, N/A |
| Melinta Therapeutics, LLC | $232.51 | 2020-2022 | |
| Crossroads Extremity Systems, LLC | $216.80 | 2021 | |
| Osiris Therapeutics INC. | $165.02 | 2019 | |
| Alafair Biosciences, INC. | $149.20 | 2024 | Versawrap |
| Averitas Pharma INC. | $102.50 | 2024 | Qutenza |
| Treace Medical Concepts, INC. | $51.16 | 2022-2023 | |
| Abbvie INC. | $36.79 | 2022-2024 | |
| Ossio INC | $22.36 | 2021 | |
| Organogenesis INC. | $20.70 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $20.41 | 2023 | Nuzyra |
| Medinc of Texas | $17.86 | 2024 | |
| Nevro Corp. | $15.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.